You are here

Article info

Article menu
Download PDFPDF
Pancreatic cancer
Original article
Genetic inactivation of Nupr1 acts as a dominant suppressor event in a two-hit model of pancreatic carcinogenesis

Authors

  • Carla E Cano Centre de Recherche en Carcérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France PubMed articlesGoogle scholar articles
  • Tewfik Hamidi Centre de Recherche en Carcérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France PubMed articlesGoogle scholar articles
  • Maria Noé Garcia Centre de Recherche en Carcérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France PubMed articlesGoogle scholar articles
  • Daniel Grasso Centre de Recherche en Carcérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France PubMed articlesGoogle scholar articles
  • Céline Loncle Centre de Recherche en Carcérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France PubMed articlesGoogle scholar articles
  • Stéphane Garcia Centre de Recherche en Carcérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France PubMed articlesGoogle scholar articles
  • Ezequiel Calvo Molecular Endocrinology and Oncology Research Center, CHUL Research Center, Quebec, Canada PubMed articlesGoogle scholar articles
  • Gwen Lomberk Laboratory of Epigenetics and Chromatin Dynamics, Epigenomics Translational Program, Mayo Clinic Center for Individualized Medicine, Division of Gastroenterology and Hepatology, Rochester, Minnesota, USA Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA PubMed articlesGoogle scholar articles
  • Nelson Dusetti Centre de Recherche en Carcérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France PubMed articlesGoogle scholar articles
  • Laurent Bartholin INSERM U1052, CNRS UMR 5286, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, University of Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Raul Urrutia Laboratory of Epigenetics and Chromatin Dynamics, Epigenomics Translational Program, Mayo Clinic Center for Individualized Medicine, Division of Gastroenterology and Hepatology, Rochester, Minnesota, USA Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA PubMed articlesGoogle scholar articles
  • Juan L Iovanna Centre de Recherche en Carcérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Juan L Iovanna, Centre de Recherche en Carcérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, 163 Av de Luminy, Campus de Luminy, Marseille 13288, France; juan.iovanna{at}inserm.fr
View Full Text

Citation

Cano CE, Hamidi T, Garcia MN, et al
Genetic inactivation of Nupr1 acts as a dominant suppressor event in a two-hit model of pancreatic carcinogenesis
Gut 2014;63:984-995.

Publication history

  • Received May 10, 2013
  • Accepted July 29, 2013
  • First published September 11, 2013.
Online issue publication 
October 26, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions